drugset / Trial / NCT02859337
Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA
Phase 4
Completed
64 enrolled
Oregon Health and Science University
National Institutes of Health (NIH) · collab
RandomizedCrossoverOpen-labelTreatment
Summary
Obese women are significantly more likely than their normal BMI counterparts to experience failure of orally-dosed emergency contraceptives. Our preliminary data provides evidence for testing a dose escalation strategy in an effort to provide improved efficacy from orally-dosed emergency contraceptives in obese women. More data is needed regarding emergency contraception containing ulipristal acetate. The overall project will be focused on both levonorgestrel (LNG) - and ulipristal acetate (UPA)-containing emergency contraception but this protocol registration is for the UPA aspect of the study procedures.
Timeline
- Start
- 2017-05-30
- Primary completion
- 2022-01-13
- Completion
- 2023-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ulipristal Acetate | Unknown | 30 mg | Oral |
| Subject | Ulipristal Acetate | Unknown | 60 mg | Oral |